Yayın:
Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New N-Heterocyclic Compounds as Aromatase Inhibitors

dc.contributor.authorFatih Tok
dc.contributor.authorBegüm Nurpelin Sağlık Özkan
dc.contributor.authorYusuf Özkay
dc.contributor.authorZafer Asım Kaplancıklı
dc.contributor.orcid0000-0003-2252-0923
dc.date.accessioned2026-05-20T10:16:14Z
dc.date.issued2026-01-27
dc.identifier.doi10.3390/ph19020224
dc.identifier.endpage224
dc.identifier.issn1424-8247
dc.identifier.issue2
dc.identifier.openalexW7125809482
dc.identifier.startpage224
dc.identifier.urihttps://hdl.handle.net/11421/39672
dc.identifier.urihttps://doi.org/10.3390/ph19020224
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofPharmaceuticals
dc.rightsopenAccess
dc.subjectAromatase
dc.subjectLetrozole
dc.subjectDocking (animal)
dc.subjectEnzyme
dc.subjectAromatase inhibitor
dc.subjectBreast cancer
dc.subjectStructure–activity relationship
dc.subjectCancer cell
dc.subjectActive site
dc.subject.sdg3
dc.titleDesign, Synthesis, Biological Evaluation and Molecular Docking Studies of New N-Heterocyclic Compounds as Aromatase Inhibitors
dspace.entity.typePublication

Dosyalar

Koleksiyonlar